Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ROCK & ASSOCIATES ON BEHALF OF PARRY, ROMANI, DECONCINI & SYMMS via MS. TAMI WAHL
2019 · first_quarter · 1T
Working to ensure the implementation of the Drug Quality and Security Act (DQSA) (Food, Drug, and Cosmetic Act (503B)) is in alignment with the statutory language. Legislative efforts include working on draft guidance documents issued by FDA.
Working to ensure the implementation of the Drug Quality and Security Act (DQSA) (Food, Drug, and Cosmetic Act (503B)) is in alignment with the statutory language. Legislative efforts include working on draft guidance documents issued by FDA.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, White House Office
Source: Senate LDA
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: MS. TAMI WAHL
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
ROCK & ASSOCIATES via MS. TAMI WAHL
2019 · first_quarter · 1T
Appropriations to fund the implementation of regulations impacting pharmacy compounding.
Legislation impacting the operation of pharmacy compounding, and access to compounded medications.
Legislation impacting the operation of pharmacy compounding, and access to compounded medications.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES ON BEHALF OF PARRY, ROMANI, DECONCINI & SYMMS via MS. TAMI WAHL
2018 · fourth_quarter · Q4
Working to ensure the implementation of the Drug Quality and Security Act (DQSA) (Food, Drug, and Cosmetic Act (503B)) is in alignment with the statutory language. Legislative efforts include working on draft guidance documents issued by FDA.
Working to ensure the implementation of the Drug Quality and Security Act (DQSA) (Food, Drug, and Cosmetic Act (503B)) is in alignment with the statutory language. Legislative efforts include working on draft guidance documents issued by FDA.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, White House Office
ROCK & ASSOCIATES via MS. TAMI WAHL
2018 · fourth_quarter · Q4
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Appropriations to fund the implementation of regulations impacting pharmacy compounding.
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES ON BEHALF OF PARRY, ROMANI, DECONCINI & SYMMS via MS. TAMI WAHL
2018 · third_quarter · Q3
Working to ensure the implementation of the Drug Quality and Security Act (DQSA) (Food, Drug, and Cosmetic Act (503B)) is in alignment with the statutory language. Legislative efforts include working on draft guidance documents issued by FDA.
Working to ensure the implementation of the Drug Quality and Security Act (DQSA) (Food, Drug, and Cosmetic Act (503B)) is in alignment with the statutory language. Legislative efforts include working on draft guidance documents issued by FDA.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES ON BEHALF OF PARRY, ROMANI, DECONCINI & SYMMS via MS. TAMI WAHL
2018 · third_quarter · RR
Legislation and matters impacting the operation of outsourcing facilities (FDCA 503B), and patients access to compounded medications.
Legislation and matters impacting the operation of outsourcing facilities (FDCA 503B), and patients access to compounded medications.
ROCK & ASSOCIATES via MS. TAMI WAHL
2018 · third_quarter · Q3
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Appropriations to fund the implementation of regulations impacting pharmacy compounding.
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via MS. TAMI WAHL
2018 · second_quarter · Q2
Appropriations to fund the implementation of regulations impacting pharmacy compounding.
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via MS. TAMI WAHL
2018 · first_quarter · Q1
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Appropriations to fund the implementation of regulations impacting pharmacy compounding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via MS. TAMI WAHL
2017 · fourth_quarter · 4A
Appropriations to fund the implementation of regulations impacting pharmacy compounding.
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via MS. TAMI WAHL
2017 · fourth_quarter · RR
Legislation and matters impacting the operation of compounding pharmacies, and the consumer availability of compounded medications.
Legislation and matters impacting the operation of compounding pharmacies, and the consumer availability of compounded medications.
Legislation and matters impacting the operation of compounding pharmacies, and the consumer availability of compounded medications.